5α-reductase Inhibitors and Risk of High-grade or Lethal Prostate Cancer

Preston, Mark A.Wilson, KathrynMarkt, Sarah C.Ge, RongbinMorash, ChristopherStampfer, MeirLoda, Massimo F.Giovannucci, EdwardMucci, Lorelei A.Olumi, Aria F.2019-09-052014Preston, Mark A., Kathryn M. Wilson, Sarah C. Markt, Rongbin Ge, Christopher Morash, Meir J. Stampfer, Massimo Loda, Edward Giovannucci, Lorelei A. Mucci, and Aria F. Olumi. 2014. “5α-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer.” JAMA Internal Medicine 174 (8): 1301. https://doi.org/10.1001/jamainternmed.2014.1600.2168-61062168-6114http://nrs.harvard.edu/urn-3:HUL.InstRepos:41292549en-US5α-reductase Inhibitors and Risk of High-grade or Lethal Prostate CancerJournal Article2019-09-0510.1001/jamainternmed.2014.1600